Dexcom Appoints Jon Coleman as Chief Commercial Officer

On March 25, 2025, DexCom, Inc. announced the appointment of Jon Coleman as its new chief commercial officer. Coleman will lead the company’s global commercial operations, including sales, marketing, and customer experience.

Coleman brings over 30 years of leadership experience across healthcare sectors. He previously held executive roles at Masimo Corporation, including president of global commercial operations, and served in senior positions at Pfizer’s Consumer Healthcare division, where he led growth across regions such as Asia, Latin America, and Canada. His background also includes roles at Procter & Gamble and Bain & Company.

Dexcom CEO Kevin Sayer praised Coleman’s track record in navigating global healthcare markets and driving growth. Coleman expressed enthusiasm about joining Dexcom at a pivotal time, citing the company's commitment to innovation in glucose biosensing and its potential for global health impact.